While the data on SHBG in bone cancers and metastasis are sparse, one publication noted that in patients with prostate cancer, higher serum SHBG levels were associated with reduced bone mineral density and osteoporosis [40]. The gene discussed is SHBG; the disease is prostate carcinoma.